Early Prognostic Indicators of Subsequent Hospitalization in Patients with Mild COVID-19

Comprehensive data on early prognostic indicators in patients with mild COVID-19 remains sparse. In this single center case series, we characterized the initial clinical presentation in 180 patients with mild COVID-19 and defined the earliest predictors of subsequent deterioration and need for hospi...

Full description

Bibliographic Details
Main Authors: Alyssa Ylescupidez, Aaron Rips, Henry T. Bahnson, Cate Speake, Punam Verma, Anne M. Hocking, Jane H. Buckner, Uma Malhotra
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/8/1562
_version_ 1797538474145873920
author Alyssa Ylescupidez
Aaron Rips
Henry T. Bahnson
Cate Speake
Punam Verma
Anne M. Hocking
Jane H. Buckner
Uma Malhotra
author_facet Alyssa Ylescupidez
Aaron Rips
Henry T. Bahnson
Cate Speake
Punam Verma
Anne M. Hocking
Jane H. Buckner
Uma Malhotra
author_sort Alyssa Ylescupidez
collection DOAJ
description Comprehensive data on early prognostic indicators in patients with mild COVID-19 remains sparse. In this single center case series, we characterized the initial clinical presentation in 180 patients with mild COVID-19 and defined the earliest predictors of subsequent deterioration and need for hospitalization. Three broad patient phenotypes and four symptom clusters were characterized, differentiated by varying risk for adverse outcomes. Among 14 symptoms assessed, subjective shortness of breath (SOB) most strongly associated with adverse outcomes (odds ratio (OR) 21.3, 95% confidence interval (CI): 2.7–166.4; <i>p</i> < 0.0001). In combination, SOB and number of comorbidities were highly predictive of subsequent hospitalization (area under the curve (AUC) 92%). Additionally, initial lymphopenia (OR 21.0, 95% CI: 2.1–210.1; <i>p</i> = 0.002) and male sex (OR 3.5, 95% CI: 0.9–13.0; <i>p</i> = 0.05) were associated with increased risk of poor outcomes. Patients with known comorbidities, especially multiple, and those presenting with subjective SOB or lymphopenia should receive close monitoring and consideration for preemptive treatment, even when presenting with mild symptoms.
first_indexed 2024-03-10T12:30:53Z
format Article
id doaj.art-6778f702be3d4f35a5ed4f436bde642c
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T12:30:53Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-6778f702be3d4f35a5ed4f436bde642c2023-11-21T14:37:33ZengMDPI AGJournal of Clinical Medicine2077-03832021-04-01108156210.3390/jcm10081562Early Prognostic Indicators of Subsequent Hospitalization in Patients with Mild COVID-19Alyssa Ylescupidez0Aaron Rips1Henry T. Bahnson2Cate Speake3Punam Verma4Anne M. Hocking5Jane H. Buckner6Uma Malhotra7Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101, USACenter for Interventional Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101, USACenter for Interventional Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101, USACenter for Interventional Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101, USADepartment of Microbiology, Virginia Mason Medical Center, Seattle, WA 98101, USACenter for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101, USACenter for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101, USADepartment of Infectious Disease, Virginia Mason Medical Center, Seattle, WA 98101, USAComprehensive data on early prognostic indicators in patients with mild COVID-19 remains sparse. In this single center case series, we characterized the initial clinical presentation in 180 patients with mild COVID-19 and defined the earliest predictors of subsequent deterioration and need for hospitalization. Three broad patient phenotypes and four symptom clusters were characterized, differentiated by varying risk for adverse outcomes. Among 14 symptoms assessed, subjective shortness of breath (SOB) most strongly associated with adverse outcomes (odds ratio (OR) 21.3, 95% confidence interval (CI): 2.7–166.4; <i>p</i> < 0.0001). In combination, SOB and number of comorbidities were highly predictive of subsequent hospitalization (area under the curve (AUC) 92%). Additionally, initial lymphopenia (OR 21.0, 95% CI: 2.1–210.1; <i>p</i> = 0.002) and male sex (OR 3.5, 95% CI: 0.9–13.0; <i>p</i> = 0.05) were associated with increased risk of poor outcomes. Patients with known comorbidities, especially multiple, and those presenting with subjective SOB or lymphopenia should receive close monitoring and consideration for preemptive treatment, even when presenting with mild symptoms.https://www.mdpi.com/2077-0383/10/8/1562COVID-19SARS CoV-2pathophysiologyprognostic indicatorspandemiccomorbidities
spellingShingle Alyssa Ylescupidez
Aaron Rips
Henry T. Bahnson
Cate Speake
Punam Verma
Anne M. Hocking
Jane H. Buckner
Uma Malhotra
Early Prognostic Indicators of Subsequent Hospitalization in Patients with Mild COVID-19
Journal of Clinical Medicine
COVID-19
SARS CoV-2
pathophysiology
prognostic indicators
pandemic
comorbidities
title Early Prognostic Indicators of Subsequent Hospitalization in Patients with Mild COVID-19
title_full Early Prognostic Indicators of Subsequent Hospitalization in Patients with Mild COVID-19
title_fullStr Early Prognostic Indicators of Subsequent Hospitalization in Patients with Mild COVID-19
title_full_unstemmed Early Prognostic Indicators of Subsequent Hospitalization in Patients with Mild COVID-19
title_short Early Prognostic Indicators of Subsequent Hospitalization in Patients with Mild COVID-19
title_sort early prognostic indicators of subsequent hospitalization in patients with mild covid 19
topic COVID-19
SARS CoV-2
pathophysiology
prognostic indicators
pandemic
comorbidities
url https://www.mdpi.com/2077-0383/10/8/1562
work_keys_str_mv AT alyssaylescupidez earlyprognosticindicatorsofsubsequenthospitalizationinpatientswithmildcovid19
AT aaronrips earlyprognosticindicatorsofsubsequenthospitalizationinpatientswithmildcovid19
AT henrytbahnson earlyprognosticindicatorsofsubsequenthospitalizationinpatientswithmildcovid19
AT catespeake earlyprognosticindicatorsofsubsequenthospitalizationinpatientswithmildcovid19
AT punamverma earlyprognosticindicatorsofsubsequenthospitalizationinpatientswithmildcovid19
AT annemhocking earlyprognosticindicatorsofsubsequenthospitalizationinpatientswithmildcovid19
AT janehbuckner earlyprognosticindicatorsofsubsequenthospitalizationinpatientswithmildcovid19
AT umamalhotra earlyprognosticindicatorsofsubsequenthospitalizationinpatientswithmildcovid19